Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-03
DOI
10.1038/s41598-017-07452-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growth
- (2016) Orazio Vittorio et al. Oncotarget
- Endothelial Antioxidant-1: a Key Mediator of Copper-dependent Wound Healing in vivo
- (2016) Archita Das et al. Scientific Reports
- Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function
- (2015) Gin-Fu Chen et al. Scientific Reports
- Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
- (2014) Naveen S. Vasudev et al. ANGIOGENESIS
- Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse
- (2013) S. Jain et al. ANNALS OF ONCOLOGY
- Characterization of a monoclonal antibody capable of reliably quantifying expression of Human Copper Transporter 1 (hCTR1)
- (2013) Jacob F. Quail et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- CTR1 Silencing Inhibits Angiogenesis by Limiting Copper Entry into Endothelial Cells
- (2013) Gomathy Narayanan et al. PLoS One
- Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
- (2012) B. Sitohy et al. CANCER RESEARCH
- Dextran-Catechin Conjugate: A Potential Treatment Against the Pancreatic Ductal Adenocarcinoma
- (2012) Orazio Vittorio et al. PHARMACEUTICAL RESEARCH
- Copper stimulates growth of human umbilical vein endothelial cells in a vascular endothelial growth factor-independent pathway
- (2011) Shun Li et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Bioinorganic aspects of angiogenesis
- (2010) Luca Domenico D'Andrea et al. DALTON TRANSACTIONS
- The significance of copper chelators in clinical and experimental application
- (2010) Xueqin Ding et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Cancer Chemoprevention by Natural Products: How Far Have We Come?
- (2010) Rajendra G. Mehta et al. PHARMACEUTICAL RESEARCH
- VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2
- (2009) Z Zhang et al. CELL DEATH AND DIFFERENTIATION
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial
- (2008) M de Lima et al. BONE MARROW TRANSPLANTATION
- Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
- (2008) Anshul Gupte et al. CANCER TREATMENT REVIEWS
- Novel Role of Antioxidant-1 (Atox1) as a Copper-dependent Transcription Factor Involved in Cell Proliferation
- (2008) Shinichi Itoh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started